Condition: Pediatric Disorder · Genetic Predisposition · Dystonia, Secondary · Sponsor: Children's Mercy Hospital Kansas City
This study looks at how a medicine called trihexyphenidyl works in children with dystonic cerebral palsy. The study aims to understand how trihexyphenidyl is broken down and used in the body of pediatric patients and whether this is impacted by a person's genetics. Information from this study will also be used to design future clinical trials.
This description comes directly from the study's public registry record.
Rose Gelineau-Morel, MD · 816-302-3331 · rngelineaumorel@cmh.edu
Rachel Nass · 8166011354 · rnass@cmh.edu
Always discuss trial participation with your own doctor first.
| Children's Mercy Hospital Kansas City | Kansas City, Missouri, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06554288